Results 41 to 50 of about 79,696 (205)

Evolution of Phosphodiesterase-5 Inhibitors

open access: yesThe World Journal of Men's Health, 2015
After the launch of sildenafil citrate (Viagra®), the last great invention of the 20th century, in 1998, oral phosphodiesterase (PDE)-5 inhibitors were established as first-line treatment for erectile dysfunction (ED), representing a paradigm shift in the diagnosis and treatment of ED [1].
openaire   +2 more sources

Tonic and phasic nitric oxide signals in hippocampal long-term potentiation [PDF]

open access: yes, 2006
Nitric oxide ( NO) participates in long-term potentiation (LTP) and other forms of synaptic plasticity in many different brain areas but where it comes from and how it acts remain controversial.
Garthwaite, J, Hopper, RA
core   +1 more source

Why humans need type 5 phosphodiesterase inhibitors [PDF]

open access: yesInternational Journal of Andrology, 2005
SummaryErectile dysfunction (ED) is a widespread medical condition affecting millions of males at any age and requiring medical treatment. ED may simply reflect a limit of human physiology, yet ED equates to genetic death and the high prevalence of ED is a clear evolutionary paradox.
CELLERINO, Alessandro, JANNINI E. A.
openaire   +3 more sources

DNA single-strand break repair and spinocerebellar ataxia with axonal neuropathy-1 [PDF]

open access: yes, 2007
DNA single-strand breaks (SSBs) are the commonest DNA lesions arising spontaneously in cells, and if not repaired may block transcription or may be converted into potentially lethal/clastogenic DNA double-strand breaks (DSBs).
Arnaudeau   +82 more
core   +1 more source

Regulation of the G2/M Transition in Rodent Oocytes [PDF]

open access: yes, 2010
Regulation of maturation in meiotically competent mammalian oocytes is a complex process involving the carefully coordinated exchange of signals between the somatic and germ cell compartments of the ovarian follicle via paracrine and cell–cell coupling ...
Downs, Stephen
core   +2 more sources

Efficacy and Safety of Udenafil Once Daily in Patients with Erectile Dysfunction after Bilateral Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy: A Randomized, Double-Blind, Placebo-Controlled Study

open access: yesThe World Journal of Men's Health, 2023
Purpose: To evaluate the efficacy and safety of udenafil 75 mg once daily in patients with erectile dysfunction following bilateral nerve-sparing robot-assisted laparoscopic radical prostatectomy (BNS-RALP).
Jae Hoon Chung   +8 more
doaj   +1 more source

PDE5 inhibitor drugs for use in dementia

open access: yesAlzheimer’s & Dementia: Translational Research & Clinical Interventions, 2023
Alzheimer's disease and related dementias (ADRD) remain a major health‐care challenge with few licensed medications. Repurposing existing drugs may afford prevention and treatment.
Atticus H. Hainsworth   +4 more
doaj   +1 more source

Phosphodiesterase Type 5 Inhibitors Greatly Affect Physicochemical Properties of Model Lipid Membranes

open access: yesMembranes, 2021
Although phosphodiesterase type 5 inhibitors are widely used and well-studied drugs, the potential benefits of their application in the treatment of various diseases and new drug delivery systems, including liposome forms, are still being discussed.
Anastasiia A. Zakharova   +2 more
doaj   +1 more source

Erectile dysfunction - an update of current practice and future strategies [PDF]

open access: yes, 2013
Erectile dysfunction (ED) is defined as the inability to achieve and maintain a penile erection adequate for satisfactory sexual intercourse.1 Up to 150 million men worldwide suffer from ED and this figure is likely to double by the year 2025.2 A number
Kalsi, J, Muneer, A
core   +1 more source

PHOSPHODIESTERASE 5 INHIBITORS IN TESTIS TORSION: AN EXPERIMENTAL STUDY

open access: yesUrology Research and Practice, 2019
-
Turgay AKGÜL   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy